News and Announcements
Tesserent Quarterly Activities Report; Sales Increased By 12%
- Published November 01, 2016 11:11AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
31st October 2016, ASX Announcement
Tesserent Limited (ASX: TNT) is pleased to deliver the September Quarterly Financial and Activities Report, highlighted by execution of the Company’s planned growth strategy and an increase in quarterly sales by 12%.
Key highlights during the quarter:
- Customer receipts increased by 12% on previous quarter from $1.107m to $1.240m
- Quarter on quarter receivables maintained at stable rate
- Asian markets Business Development Manager appointed
- Renewed and upgraded several existing customers • Continue to sign-up new customers
- US channel partner commences, delivering solid growth
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
